Salvatore Calabrese

Insider Reports History

Entity
Individual
Location
C/O Gain Therapeutics, Inc., 4800 Hampden Lane, Suite 200, Bethesda, MD
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salvatore Calabrese:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 25K $62.5K $2.50 Mar 23, 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 50K Mar 23, 2023 Direct

Insider Reports Filed by Salvatore Calabrese

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Mar 23, 2023 2 $0 4 Mar 27, 2023 Chief Financial Officer
GANX Gain Therapeutics, Inc. Jul 15, 2022 2 $0 4 Jul 19, 2022 Chief Financial Officer
GANX Gain Therapeutics, Inc. May 19, 2022 1 $8.1K 4/A May 23, 2022 CHIEF FINANCIAL OFFICER